• Thumbnail for Ursodoxicoltaurine
    Ursodoxicoltaurine is the international nonproprietary name (INN) for the pharmaceutical form of tauroursodeoxycholic acid (TUDCA). It is also known as...
    16 KB (1,569 words) - 20:20, 11 October 2024
  • Sodium phenylbutyrate/ursodoxicoltaurine, also known as sodium phenylbutyrate/taurursodiol and sold under the brand names Albrioza and Relyvrio, is a fixed-dose...
    20 KB (1,270 words) - 21:00, 21 June 2024
  • Thumbnail for ALS
    riluzole (extends life by two to three months) and sodium phenylbutyrate/ursodoxicoltaurine (extends life by around seven months). Non-invasive ventilation may...
    131 KB (14,038 words) - 11:12, 29 September 2024
  • Ursodeoxycholic acid A05AA03 Cholic acid A05AA04 Obeticholic acid A05AA05 Ursodoxicoltaurine A05AB01 Nicotinyl methylamide A05AX01 Piprozolin A05AX02 Hymecromone...
    1 KB (244 words) - 04:01, 18 December 2023
  • Thumbnail for Brian Wallach
    Drug Administration (FDA) approve the ALS drug sodium phenylbutyrate/ursodoxicoltaurine. A network of non-profits, including I AM ALS, submitted more than...
    13 KB (1,232 words) - 05:21, 14 October 2024
  • Arimoclomol N07XX18 Vutrisiran N07XX19 Sodium phenylbutyrate and ursodoxicoltaurine N07XX21 Eplontersen N07XX22 Tofersen N07XX23 Troriluzole N07XX59 Dextromethorphan...
    2 KB (282 words) - 23:28, 21 December 2023